Arbutus Biopharma (ABUS) - Management Comments

Arbutus Biopharma (ABUS) – Management Comments

Jan 24, 2022 07:33 AM Arbutus Biopharma (ABUS) Announces 2022 Corporate Objectives and Provides Financial Update
Apr 1, 2021 07:33 AM Arbutus Biopharma (ABUS), X-Chem and Proteros biostructures Enter into a Pan-Coronavirus Discovery Research and License Agreement
Nov 16, 2020 06:13 AM
Aug 27, 2020 08:10 AM
Aug 7, 2020 07:42 AM
May 11, 2020 06:14 AM
Mar 26, 2020 04:16 PM
Feb 10, 2020 08:04 AM
Nov 6, 2019 07:40 AM
Oct 3, 2019 04:06 PM
Aug 20, 2019 04:07 PM
Aug 5, 2019 07:37 AM
Jul 15, 2019 04:09 PM
Jul 2, 2019 04:03 PM
Jun 20, 2019 07:32 AM
Jun 17, 2019 07:32 AM
Nov 26, 2018 04:43 PM
Oct 22, 2018 08:38 AM
Aug 13, 2018 08:33 AM
Jun 7, 2018 05:45 PM
Feb 8, 2018 08:32 AM
Nov 13, 2017 05:41 PM
Oct 18, 2017 08:09 AM
Oct 2, 2017 07:01 AM
Sep 25, 2017 08:01 AM
Sep 20, 2017 12:25 PM
Jul 27, 2017 07:59 AM
Mar 23, 2017 04:32 PM
Dec 12, 2016 04:02 PM
Jul 18, 2016 05:02 PM
Apr 22, 2016 08:11 AM
Jul 20, 2015 08:31 AM